These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25330558)

  • 1. Diagnostic method patents and harms to follow-on innovation.
    Harv Law Rev; 2013 Mar; 126(5):1370-91. PubMed ID: 25330558
    [No Abstract]   [Full Text] [Related]  

  • 2. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Supreme Court free genes - economic and legal justifications - impacts on innovation and the healthcare offer].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2015 Feb; 31(2):209-13. PubMed ID: 25744269
    [No Abstract]   [Full Text] [Related]  

  • 4. Supreme Court ruling broadens BRCA testing options.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Nov; 105(22):1671-2. PubMed ID: 24198329
    [No Abstract]   [Full Text] [Related]  

  • 5. US personalized-medicine industry takes hit from Supreme Court.
    Ledford H
    Nature; 2016 Aug; 536(7617):382. PubMed ID: 27558042
    [No Abstract]   [Full Text] [Related]  

  • 6. Supreme Court rules against gene patents.
    Kuehn BM
    JAMA; 2013 Jul; 310(4):357-9. PubMed ID: 23917268
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequenom, the U.S. Supreme Court, and Personalized Medicine.
    Kodroff CA
    Hum Gene Ther Clin Dev; 2016 Jun; 27(2):49-52. PubMed ID: 27267566
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging patent issues in genomic diagnostics.
    Barton JH
    Nat Biotechnol; 2006 Aug; 24(8):939-41. PubMed ID: 16900135
    [No Abstract]   [Full Text] [Related]  

  • 9. A little light on the Mayo: justifying reversal of the Federal Circuit's Association for Molecular Pathology decision.
    Georgek KJ
    Seton Hall Law Rev; 2014; 44(1):171-206. PubMed ID: 24654292
    [No Abstract]   [Full Text] [Related]  

  • 10. Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid.
    Dyer C
    BMJ; 2012 Dec; 345():e8266. PubMed ID: 23223689
    [No Abstract]   [Full Text] [Related]  

  • 11. Data disclosure crucial after DNA patent verdict.
    de Costa A
    Science; 2013 Aug; 341(6149):959. PubMed ID: 23990544
    [No Abstract]   [Full Text] [Related]  

  • 12. U.S. Supreme Court decision paves way for better genetic testing: ruling bars exclusive licensing, patents on naturally occurring genes.
    Levenson D
    Am J Med Genet A; 2013 Sep; 161A(9):ix-x. PubMed ID: 23946205
    [No Abstract]   [Full Text] [Related]  

  • 13. KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.
    Bouchard RA
    Health Law J; 2007; 15():247-94. PubMed ID: 19702185
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene patenting--the Supreme Court finally speaks.
    Kesselheim AS; Cook-Deegan RM; Winickoff DE; Mello MM
    N Engl J Med; 2013 Aug; 369(9):869-75. PubMed ID: 23841703
    [No Abstract]   [Full Text] [Related]  

  • 15. The fate and future of patents on human genes and genetic diagnostic methods.
    Huys I; Matthijs G; Van Overwalle G
    Nat Rev Genet; 2012 May; 13(6):441-8. PubMed ID: 22596320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers unbound--the Supreme Court's ruling on diagnostic-test patents.
    Kesselheim AS; Karlawish J
    N Engl J Med; 2012 Jun; 366(25):2338-40. PubMed ID: 22621421
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene patenting--is the pendulum swinging back?
    Kesselheim AS; Mello MM
    N Engl J Med; 2010 May; 362(20):1855-8. PubMed ID: 20375396
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequenom v. Ariosa - The Death of a Genetic Testing Patent.
    Cook-Deegan R; Chandrasekharan S
    N Engl J Med; 2016 Dec; 375(25):2418-2419. PubMed ID: 28002697
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent watch: Diagnostic patents at risk after Federal Circuit decisions.
    Noonan K
    Nat Rev Drug Discov; 2016 Jun; 15(6):377. PubMed ID: 27199249
    [No Abstract]   [Full Text] [Related]  

  • 20. On access and accountability--two Supreme Court rulings on generic drugs.
    Boumil MM; Curfman GD
    N Engl J Med; 2013 Aug; 369(8):696-7. PubMed ID: 23923990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.